Clincosm LogoSign in Get a demo

Melanoma

Showing NaN - NaN of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Lymph Node Cancer Trial in Pittsburgh (CMP-001, Nivolumab)

Active, not recruiting
Has Results
  • Melanoma
  • Lymph Node Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 15, 2022

Melanoma Trial in Pittsburgh (drug, biological, other)

Recruiting
  • Melanoma
  • Vidutolimod (CMP-001)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 25, 2022

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Melanoma Trial in Pittsburgh (encorafenib, nivolumab, ipilimumab)

Recruiting
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 24, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Metabolic and Immune Dysfunction in In-transit Melanoma

Recruiting
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 11, 2022

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    Renal Cell Carcinoma, Melanoma, Solid Tumor Trial in Pittsburgh (Phase Ib ARRY-614 + nivolumab, Phase Ib ARRY-614 +

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Phase Ib ARRY-614 + nivolumab
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 9, 2022

    Melanoma Trial in Pittsburgh (Pembrolizumab, Vemurafenib, Cobimetinib)

    Terminated
    • Melanoma
    • Pittsburgh, Pennsylvania
      UPMC Cancer Center Hillman Cancer Center
    Dec 10, 2021

    Melanoma Trial in United States (Ipilimumab, Nivolumab)

    Completed
    Has Results
    • Melanoma
    • Duarte, California
    • +35 more
    Sep 8, 2021

    Melanoma, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (Enoblituzumab, Pembrolizumab, MGA012)

    Completed
    • Melanoma
    • +3 more
    • Enoblituzumab
    • +2 more
    • Scottsdale, Arizona
    • +19 more
    Sep 22, 2021

    Solid Tumor, Melanoma, NSCLC Trial in Australia, United States (T3011, T3011 + pembrolizumab)

    Recruiting
    • Solid Tumor
    • +2 more
    • T3011
    • T3011 + pembrolizumab
    • Gilbert, Arizona
    • +7 more
    Jun 22, 2021

    Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)

    Active, not recruiting
    • Metastatic Cancer
    • +4 more
    • VE800
    • +2 more
    • Scottsdale, Arizona
    • +17 more
    Jun 22, 2021

    Melanoma Trial in Pittsburgh (MK-3475, Peginterferon alfa-2b)

    Completed
    • Melanoma
    • Pittsburgh, Pennsylvania
      Hillman Cancer Center
    May 3, 2021

    Melanoma Trial in Louisville, Pittsburgh, Houston (TKI258)

    Completed
    • Melanoma
    • Louisville, Kentucky
    • +2 more
    Mar 9, 2021

    Melanoma Trial in Worldwide (GSK 2132231A, Placebo)

    Terminated
    Has Results
    • Melanoma
    • GSK 2132231A
    • Placebo
    • Birmingham, Alabama
    • +256 more
    Feb 5, 2021

    Melanoma, Head and Neck Squamous Cell Carcinoma, Solid Tumor Trial in Philadelphia, Pittsburgh, Houston (SB 11285, Atezolizumab)

    Recruiting
    • Melanoma
    • +2 more
    • Philadelphia, Pennsylvania
    • +2 more
    Dec 21, 2020

    B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

    Completed
    • B-cell Malignancies
    • +7 more
    • Nivolumab (Phase 1)
    • +4 more
    • Birmingham, Alabama
    • +23 more
    Aug 26, 2020

    Melanoma Molecular Profiling Analysis

    Completed
    • Melanoma
    • Biospecimen banking
    • Pittsburgh, Pennsylvania
      Hillman Cancer Center
    Jun 5, 2020

    Solid Tumors, Mycosis Fungoides, Melanoma Trial in United States (TTI-621 Monotherapy, TTI-621 + PD-1/PD-L1 Inhibitor, TTI-621 +

    Terminated
    • Solid Tumors
    • +7 more
    • TTI-621 Monotherapy
    • +4 more
    • Duarte, California
    • +6 more
    May 13, 2020

    Rhabdomyosarcoma, Melanoma Trial in United States (Tc99m tilmanocept, Vital Blue Dye (optional), Lymph Node Mapping)

    Completed
    • Rhabdomyosarcoma
    • Melanoma
    • Tc99m tilmanocept
    • +2 more
    • Jacksonville, Florida
    • +5 more
    Mar 5, 2020

    Refractory Solid Tumors, Melanoma Trial in Israel, United States (IMO-2125)

    Completed
    • Refractory Solid Tumors
    • Melanoma
    • Scottsdale, Arizona
    • +11 more
    Feb 10, 2020

    Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)

    Completed
    • Lung Cancer
    • +7 more
    • Chicago, Illinois
    • +5 more
    Nov 15, 2019

    CNS and Extracranial Tumor Tissues, CSF, and Blood From Melanoma

    Completed
    • Melanoma
    • Brain Metastases
    • Craniotomy scheduled
    • Collection for non-craniotomy
    • Pittsburgh, Pennsylvania
    • +2 more
    Oct 2, 2019

    Melanoma Trial in United States (Epacadostat, Placebo, ipilimumab)

    Terminated
    • Melanoma
    • Los Angeles, California
    • +6 more
    Mar 19, 2019